1. Home
  2. LXRX vs CRI Comparison

LXRX vs CRI Comparison

Compare LXRX & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

SELL

Current Price

$1.79

Market Cap

996.7M

Sector

Health Care

ML Signal

SELL

Logo Carter's Inc.

CRI

Carter's Inc.

SELL

Current Price

$34.87

Market Cap

1.2B

ML Signal

SELL

Company Overview

Basic Information
Metric
LXRX
CRI
Founded
1995
1865
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
996.7M
1.2B
IPO Year
2000
2002

Fundamental Metrics

Financial Performance
Metric
LXRX
CRI
Price
$1.79
$34.87
Analyst Decision
Buy
Hold
Analyst Count
6
7
Target Price
$4.52
★ $36.50
AVG Volume (30 Days)
★ 2.0M
1.2M
Earning Date
11-05-2026
10-30-2026
Dividend Yield
N/A
★ 2.85%
EPS Growth
★ 77.78
N/A
EPS
N/A
★ 4.27
Revenue
$49,803,000.00
★ $2,898,426,000.00
Revenue This Year
N/A
$0.93
Revenue Next Year
N/A
$0.59
P/E Ratio
★ N/A
$8.22
Revenue Growth
★ 60.24
1.91
52 Week Low
$1.10
$27.86
52 Week High
$2.68
$44.44

Technical Indicators

Market Signals
Indicator
LXRX
CRI
Relative Strength Index (RSI) 57.67 57.86
Support Level $1.48 $34.75
Resistance Level $1.96 $35.52
Average True Range (ATR) 0.11 1.51
MACD 0.04 0.26
Stochastic Oscillator 70.65 89.47

Price Performance

Historical Comparison
LXRX
CRI

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: